Skip to content

NBTX

Nanobiotix SA

NASDAQ · Healthcare · Biotechnology · FR

$21.08
−1.03%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue18.7M29.6M(7.2M)36.2M4.8M
Cost of Revenue—————
Gross Profit18.7M29.6M(7.2M)36.2M4.8M
Operating Expenses
R&D Expense53.5M23.1M40.5M38.4M32.6M
SG&A Expense40.6M20.2M20.5M22.0M17.9M
General & Admin Expense8.9M20.2M———
Selling & Marketing Expense—————
Other Expenses(1.9M)(2.9M)134.0K2.5M985.0K
Total Operating Expenses92.2M40.5M61.2M63.0M51.5M
Cost and Expenses92.2M40.5M61.2M63.0M51.5M
Operating Income (EBIT)(73.5M)(10.8M)(68.4M)(26.8M)(46.7M)
Non-Operating
Interest Income1.7M985.0K2.6M1.2M256.0K
Interest Expense25.1M10.4M8.1M8.0M5.8M
Net Interest Income(23.5M)(9.4M)(5.5M)(6.8M)(5.6M)
Other Non-Op Income/Expense(31.1M)(13.1M)361.0K(12.8M)(10.3M)
Non-Operating Income (excl Interest)2.7M2.7M(134.0K)(2.5M)(985.0K)
EBT (Pre-Tax Income)(104.5M)(24.0M)(68.0M)(39.6M)(57.0M)
Income Tax Expense(24.0K)3.0K101.0K120.0K10.0K
Bottom Line
Net Income(105.0M)(24.0M)(68.1M)(39.7M)(57.0M)
Earnings from Cont. Ops(104.5M)(24.0M)(68.1M)(39.7M)(57.0M)
Earnings from Discont. Ops—————
Bottom Line Net Income(105.0M)(24.0M)(68.1M)(39.7M)(57.0M)
Per Share
Basic EPS($2.19)($0.50)($1.44)($1.08)($1.64)
Diluted EPS($2.19)($0.50)($1.44)($1.08)($1.64)
Revenue Per Share$0.38$0.62($0.15)$0.99$0.14
Shares
Basic Shares Outstanding48.9M47.8M47.3M36.8M34.9M
Diluted Shares Outstanding48.9M47.8M47.3M36.9M34.9M
Profitability Metrics
EBITDA(75.2M)(12.1M)(66.6M)(22.7M)(44.2M)
D&A3.2M1.5M1.6M1.5M1.5M
EBIT(78.4M)(13.6M)(68.3M)(24.2M)(45.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026